Accelerating innovation from sample to single-cell insight
QIAGEN is expanding its single-cell offering with Parse Biosciences, adding highly scalable single-cell sequencing workflows designed to help researchers run larger studies without specialized instruments.
Single-cell sequencing enables scientists to interrogate complex biology across neuroscience, immunology, oncology, developmental biology and drug discovery – helping them achieve higher-resolution insight into cellular states, heterogeneity and rare populations.
Parse Biosciences’ proprietary Evercode™ split-pool combinatorial barcoding technology dramatically increases the number of cells and samples per experiment while ensuring sensitive detection of even lowly expressed genes. With Evercode, data output is maximized from precious samples, delivering consistent, high-quality results at scale.
Advantages of the Evercode platform
